What labs should be ordered for a gluten sensitivity test?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Laboratory Testing for Gluten Sensitivity (Celiac Disease)

Order IgA tissue transglutaminase (tTG-IgA) as the primary screening test, combined with total IgA level to rule out IgA deficiency. 1

Primary Screening Panel

The essential initial laboratory workup consists of:

  • IgA tissue transglutaminase (tTG-IgA): This is the preferred first-line test with sensitivity of 90-97% and specificity of 96-100% 1, 2
  • Total IgA level: Must be measured simultaneously because IgA deficiency occurs in 1-3% of celiac disease patients and causes falsely negative tTG-IgA results 1

Critical Pre-Testing Requirement

The patient must be consuming gluten at the time of testing. All diagnostic serologic testing must be performed before initiating a gluten-free diet, as gluten withdrawal causes antibody levels to decline and produces false-negative results 1, 2. If the patient has already reduced gluten intake, they should consume at least three slices of wheat bread daily for 1-3 months before testing 1

Additional Testing Based on Initial Results

If IgA Deficiency is Detected (Low Total IgA):

  • IgG deamidated gliadin peptide (DGP-IgG): This is the preferred test in IgA-deficient patients with superior diagnostic accuracy (93.6% sensitivity, 99.4% specificity) 3, 4
  • IgG tissue transglutaminase (tTG-IgG): Alternative option, though less reliable than DGP-IgG 1

If tTG-IgA is Positive:

  • IgA endomysial antibody (EMA): Confirmatory test with excellent specificity of 99.6% in adults 1, 3, 2
  • When tTG-IgA exceeds 10 times the upper normal limit combined with positive EMA in a second blood sample, the positive predictive value for celiac disease is virtually 100% 1

For Children Under 2 Years:

  • Combine tTG-IgA with both IgG and IgA deamidated gliadin peptides to improve sensitivity 1, 4

Tests NOT Recommended

Do NOT order:

  • Native gliadin antibodies (AGA): No longer recommended for primary detection 1
  • IgG tissue transglutaminase alone (without documented IgA deficiency): Not specific in the absence of IgA deficiency 1
  • HLA-DQ2/DQ8 testing as initial screening: Limited diagnostic role; primarily useful for its negative predictive value to rule out celiac disease in equivocal cases 1

Important Distinction: True Gluten Sensitivity vs. Celiac Disease

If you are asking about non-celiac gluten sensitivity (a distinct entity from celiac disease), the serological pattern differs significantly:

  • IgG AGA may be positive in 56.4% of cases 5
  • IgA AGA may be positive in only 7.7% of cases with lower titers than celiac disease 5
  • tTG-IgA, EMA, and DGP-IgG are negative in non-celiac gluten sensitivity 5
  • However, there are no validated diagnostic markers for non-celiac gluten sensitivity, and diagnosis requires exclusion of celiac disease first 5

Common Pitfalls to Avoid

  • Never start a gluten-free diet before completing diagnostic workup, as this leads to false-negative serology and inconclusive biopsies 1, 3
  • Do not rely on symptoms alone to differentiate celiac disease from other gastrointestinal disorders 1
  • Do not skip total IgA measurement, as missing IgA deficiency is a frequent cause of false-negative results 1
  • Do not combine multiple tests initially in low-risk populations, as this reduces specificity without meaningful improvement in sensitivity 1

Next Steps After Positive Serology

Positive serology requires confirmation with upper endoscopy and duodenal biopsy (at least 4-6 specimens from the distal duodenum) as the gold standard for diagnosis 1, 3, 2. Serology alone, even with high titers, is insufficient for definitive diagnosis without histologic confirmation 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Celiac Disease Diagnosis and Monitoring

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Evaluating Discordant Celiac Disease Test Results

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Celiac Disease Diagnosis Using Deamidated Gliadin Antibodies

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Serological tests in gluten sensitivity (nonceliac gluten intolerance).

Journal of clinical gastroenterology, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.